A double blind study in 28 patients with chronic schizophrenia was carried out comparing L-dopa (up to 1250 mgm daily) with placebo (both groups continuing to receive regular neuroleptic medication) over a six week period. Assessments by the psychiatrists and psychologist using Rockland and Pollin Rating Scale showed differential improvement of insignificant proportions but the nurse's ratings showed clearly significant improvement in the subject group.
References
1.
BrunoA.AllegranzaA. (1965). The effect of haloperidol on the urinary excreta of dopamine, homovanillic and vanilmandelic acids in schizophrenics. Psychopharmacologia (Berlin), 8: 60.
2.
BrunoA.BozziR.AllegranzaA. (1963). L'illimizione dei principali metaboliti urinari della serotonina, dopamina, noradrenalina, adrenolina, durante tretamento con reserpina e con cloropromazina in soggetti schizosrenici. Rivista di Patalogia Nervosa e Mentale, 84: 451.
3.
BrunoA.BrunoS. (1966). Effects of L-dopa on pharmacological Parkinsonism. Acta Psychiatrica Scandinavica, 42: 264.
4.
KazutoyoInanaga (1971). Kurume Medical Journal, 18: 161.
5.
SmythiesJ. R. (1971). Clinical trials. Journal of the Royal College of Physicians, 8: 9.
6.
TobiasJose A. YaryuraMerlisSidney (1970). Levodopa and schizophrenia. Journal of the American Medical Association, 211: 1857.
